Thanks, Rohit. Good morning, everyone. Adjusted operating income was $174 million or $1.15 per diluted share compared to $1.27 per diluted share in the same period last year and $1.10 per diluted share in the first quarter of 2025. Adjusted operating return on equity was 13.4%. A detailed reconciliation of GAAP net income to adjusted operating income can be found in our earnings release. Turning to revenue drivers. New insurance written was $13 billion, up 35% sequentially and down 3% year-over-year. The sequential increase was primarily driven by mortgage origination seasonality from the spring selling season. Persistency was 82% in the second quarter, down 2 points sequentially and down 1 point year-over-year. Our portfolio remains resilient with 7% of our mortgages having rates at least 50 basis points above June's average of 6.8%. We expect elevated persistency will continue to help offset the potential impact of higher mortgage rates on the origination market. Given the combination of solid new insurance written and elevated persistency, primary insurance in force was $270 billion in the second quarter, up $2 billion or 1% from the first quarter of 2025 and $4 billion or approximately 1% year-over-year. Total net premiums earned were $245 million, flat sequentially and up modestly year-over-year. The year-over-year increase was primarily driven by premium growth from attractive adjacencies and the growth of our mortgage insurance portfolio, mostly offset by higher ceded premiums. Our base premium rate of 39.8 basis points was down 0.3 basis points sequentially, aligned with our expectation for base premium rate in 2025 to stabilize around 2024 levels. As a reminder, our base premium rate is impacted by several factors and tends to modestly fluctuate from quarter-to-quarter. Our net earned premium rate was 35.2 basis points, relatively flat sequentially. Investment income in the second quarter was $66 million, up $3 million or 5% sequentially and up $6 million or 10% year-over-year. Our new money investment yield continued to exceed 5%, lifting our overall portfolio book yield. As previously stated, while we typically hold investments to maturity, we may selectively pursue income enhancement opportunities. During the quarter, we sold certain assets that will allow us to recoup realized losses through future higher net investment income. Turning to credit performance. New delinquencies decreased sequentially to 11,600 in the quarter from 12,200 in the first quarter of 2025, in line with expected seasonal trends. Our new delinquency rate remained consistent with pre-pandemic levels and for the quarter at 1.2%, a decrease of 10 basis points compared to the 1.3% in the first quarter of 2025 and 1.1% in the second quarter of 2024. The year-over-year increase was primarily driven by higher new delinquencies from the normal loss development pattern of newer books. We maintained our claim rate on new delinquencies at 9%. Total delinquencies and the delinquency rate of 2.3% in the second quarter were flat sequentially as cures kept pace with news. Losses in the second quarter of 2025 were $25 million and the loss ratio was 10% compared to $31 million and 12%, respectively, in the first quarter of 2025 and negative $17 million and negative 7%, respectively, in the second quarter of 2024. The current quarter's reserve release was $48 million, driven by ongoing favorable cure performance and loss mitigation activities. Turning to operating expenses. Operating expenses for the second quarter of 2025 were $53 million, and the expense ratio was 22% compared to $53 million and 21%, respectively, in the first quarter of 2025 and $56 million and 23%, respectively, in the second quarter of 2024. For 2025 operating expenses, we continue to anticipate a range of $220 million to $225 million, excluding reorganization costs. We continue to operate from a strong capital and liquidity position, reinforced by our robust PMIERs sufficiency and the successful execution of our diversified CRT program. PMIERs sufficiency was 165% or $2 billion above PMIERs requirements at the end of the second quarter. As of June 30, 2025, our third-party CRT program provides $1.9 billion of PMIERs capital credit. Let me now turn to capital allocation. During the quarter, we paid out $31 million or $0.21 per share through our quarterly dividend. Today, we announced a third quarter dividend of $0.21 per common share payable September 8. In addition, we bought 2.4 million shares for $85 million in the second quarter of 2025. Through July 25, we repurchased an additional 0.8 million shares for $30 million. As Rohit mentioned earlier, we are increasing our 2025 total capital return guidance to approximately $400 million. As in the past, the final amount and form of capital return to shareholders will depend on business performance, market conditions and regulatory approvals. Overall, we are pleased with our performance in the first half of 2025, and we believe we are well positioned for the second half. We remain focused on prudently managing risk, maintaining a strong balance sheet and delivering solid returns for our shareholders. With that, let me turn the call back over to Rohit.